Risk analysis for plant-made vaccines

Transgenic Research

Volumn 14, Issue 4, 2005, Pages 449-462

  Kirk, Dwayne D ^a   McIntosh, Kim ^a   Walmsley, Amanda M ^a   Peterson, Robert K D ^b  

^a ARIZONA STATE UNIVERSITY   (United States)

^b MONTANA STATE UNIVERSITY   (United States)

Author keywords

Edible vaccine; Regulation; Risk; Transgenic plant

Indexed keywords

EDIBLE VACCINE;

ANIMAL; ARTICLE; BIOSYNTHESIS; BIOTECHNOLOGY; CULTURE TECHNIQUE; DANGEROUS GOODS; DRUG DOSAGE FORM; ENVIRONMENTAL MONITORING; GOVERNMENT; HUMAN; METABOLISM; RISK ASSESSMENT; STANDARD; TRANSGENE; TRANSGENIC PLANT; UNITED STATES;

ANIMALS; BIOTECHNOLOGY; CULTURE TECHNIQUES; DOSAGE FORMS; ENVIRONMENTAL MONITORING; HAZARDOUS SUBSTANCES; HUMANS; PLANTS, GENETICALLY MODIFIED; RISK ASSESSMENT; TRANSGENES; UNITED STATES; UNITED STATES DEPARTMENT OF AGRICULTURE; VACCINES, EDIBLE;

EID: 23744506541     PISSN: 09628819     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11248-005-5697-3     Document Type: Article

References (46)

1. T Arakawa J Yu DK Chong J Hough PC Engen WH Langridge 1998 A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes Nat Biotechnol 16 934 938
2. KS Barone DD Tolarova I Ormsby T Doetschman JG Michael 1998 Induction of oral tolerance in TGF-beta 1 null mice J Immunol 161 154 160
3. C Carrillo A Wigdorovitz PI Oliveros AM Zamorano AM Sadir GJ Salinas JM Escribano MV Borca 1998 Protective immune respon to foot-and-mouth disease virus with VP1 expressed in transgenic plants J Virol 72 1688 1690
4. S Castanon MS Marin JM Martin-Alonso JA Boga R Casais JM Humara RJ Ordas F Parra 1999 Immunization with potato plants expressing VP60 protein protects against rabbit hemorrhagic disease virus J Virol 73 4452 4455
5. S Castanon JM Martin-Alonso MS Marin JA Boga P Alonso F Parra R Ordas 2002 The effect of the promoter on expression of VP60 gene from rabbit hemorrhagic disease virus in potato plants Plant Sci 162 87 95
6. Center for Food Safety and Nutrition (1994) FDA BACKGROUNDER: Biotechnology of Food. United States Food and Drug Administration. BG 94-4. May 18, 1994. http://www.cfsan.fda.gov/∼lrd/biotechn.html, Last accessed 24 March 2005.
7. G Conko 2003 Safety, risk and the precautionary principle: rethinking precautionary approaches to the regulation of transgenic plants Transgenic Res 12 639 647
8. R Curtiss 3rd 1999 Genetically modified plants for use as oral immunogens Mucosal Immunology Update 7 10 12
9. Curtiss R, 3rd and Cardineau GA (1990) Oral immunization by transgenic plants. World Patent Application WO 90/02484. Washington University (Assignee).
10. JA DiMasi RW Hansen HG Grabowski 2003 The price of innovation: new estimates of drug development costs J Health Econ 22 151 185
11. K Fujihashi T Dohi MN Kweon JR McGhee T Koga MD Cooper S Tonegawa H Kiyono 1999 gammadelta T cells regulate mucosally induced tolerance in a dose-dependent fashion Int Immunol 11 1907 1916
12. 19), a potential malaria vaccine candidate, in tobacco Plant Sci 162 335 343
13. I Goklany 2001a Precaution without perversity: a comprehensive application of the precautionary principle to genetically modified crops Biotechnol Law Rep 20 377 396
14. I Goklany 2001b The Precautionary Principle: A Critical Appraisal of Environmental Risk Assessment Cato Institute Washington, DC
15. N Gomez A Wigdorovitz S Castanon F Gil R Ordas MV Borca JM Escribano 2000 Oral immunogenicity of the plant derived spike protein from swine-transmissible gastroenteritis coronavirus Arch Virol 145 1725 1732
16. TA Haq HS Mason JD Clements CJ Arntzen 1995 Oral immunization with a recombinant bacterial antigen produced in transgenic plants Science 268 714 716
17. JA Howard KC Donnelly 2004 A quantitative safety assessment model for transgenic protein products produced in agricultural crops J Agr Environ Ethics 17 545 558
18. G Jaffe 2004 Regulating transgenic crops: a comparative analysis of different regulatory processes Transgenic Res 13 5 19
19. J Kapusta A Modelska M Figlerowicz T Pniewski M Letellier O Lisowa V Yusibov H Koprowski A Plucienniczak AB Legocki 1999 A plant-derived edible vaccine against hepatitis B virus FASEB J 13 1796 1799
20. DD Kirk R Rempel J Pinkhasov AM Walmsley 2004 Application of Quillaja saponaria extracts as oral adjuvants for plant-made vaccines Expert Opin Biol Ther 4 947 958
21. Kirk DD, Vonhof WM, Eibner J, Mason HS, and Zhang X (2003) Model production of a potent plant-made vaccine. NFID Sixth annual conference on vaccine research, Arlington, VA, May 5-7.
22. Kirk DD and Webb SR (2005) The next 15 years: taking plant-made vaccines beyond proof of concept. Immunol Cell Biol 83: 248-256.
23. A Lightman D Sarewitz C Desser 2003 Living with the Genie: Essays on Technology and the Quest for Human Mastery Island Press Washington, D.C
24. L Liu VK Kuchroo HL Weiner 1999 B7.2 (CD86) but not B7.1 (CD80) costimulation is required for the induction of low dose oral tolerance J Immunol 163 2284 2290
25. S Ma Y Huang Z Yin R Menassa JE Brandle AM Jevnikar 2004 Induction of oral tolerance to prevent diabetes with transgenic plants requires glutamic acid decarboxylase (GAD) and IL-4 Proc Natl Acad Sci USA 101 5680 5685
26. SW Ma DL Zhao ZQ Yin R Mukherjee B Singh HY Qin CR Stiller AM Jevnikar 1997 Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance Nat Med 3 793 796
27. HS Mason TA Haq JD Clements CJ Arntzen 1998 Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene Vaccine 16 1336 1343
28. HS Mason DM Lam CJ Arntzen 1992 Expression of hepatitis B surface antigen in transgenic plants Proc Natl Acad Sci USA 89 11745 11749
29. Peterson RKD, (2002). How bad times how often: Risk as science. Agbiosafety. University of Nebraska-Lincoln. http://agbiosafety.unl.edu/ riskasscience.shtml, Last accessed 24 March 2005.
30. RKD Peterson CJ Arntzen 2004 On risk and plant-based biopharmaceuticals Trends Biotechnol 22 64 66
31. CS Prakash 1996 Edible vaccines and antibody producing plants Biotechnol Dev Monit 27 10 13
32. A Ratliff 2003 Biotechnology and pharmaceutical R&D and licensing trends: You pays your money and takes your chances J Commercial Biotechnol 10 54 59
33. Rigano MM, Alvarez ML, Pinkhasov J, Jin Y, Sala F, Arntzen CJ and Walmsley AM (2004) Production of a fusion protein consisting of the enterotoxigenic Escherichia coli heat-labile toxin B subunit and a tuberculosis antigen in Arabidopsis thaliana. Plant Cell Rep 22: 502-508.
34. Presidential/Congressional Commission on Risk Assessment and Risk Management (1997) Risk Assessment and Risk Management in Regulatory Decision-Making. Final Report, Volume 2.
35. ES Tackaberry F Prior M Bell M Tocchi S Porter J Mehic PR Ganz R Sardana I Altosaar A Dudani 2003 Increased yield of heterologous viral glycoprotein in the seeds of homozygous transgenic tobacco plants cultivated underground Genome 46 521 526
36. Tacket CO, Clements JD, Wasserman SS and Streatfield SJ (2003) Immunogenicity of a recombinant bacterial antigen delivered in transgenic corn. In NFID sixth annual conference on vaccine research, Arlington, VA, May 5-7.
37. CO Tacket HS Mason G Losonsky JD Clements MM Levine CJ Arntzen 1998 Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato Nat Med 4 607 609
38. CO Tacket HS Mason G Losonsky MK Estes MM Levine CJ Arntzen 2000 Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes J Infect Dis 182 302 305
39. CO Tacket MF Pasetti R Edelman JA Howard S Streatfield 2004 Immunogenicity of recombinant LT-B delivered orally to humans in transgenic corn Vaccine 22 4385 4389
40. Y Thanavala M Mahoney S Pal A Scott L Richter N Natarajan P Goodwin CJ Arntzen HS Mason 2005 Immunogenicity in humans of an edible vaccine for hepatitis B Proc Natl Acad Sci USA 102 3378 3382
41. RM Twyman S Schillberg R Fischer 2005 Transgenic plants in the biopharmaceutical market Expert Opin Emerg Drugs 10 185 218
42. USDA-APHIS (2004) Transcript of Agriculture Secretary Ann M. Veneman's remarks regarding Biotechnology Regulations. Washington, D.C. January 22, 2004. http://www. aphis.usda.gov/lpa/issues/biotechcomp/Transcript_of_Biotech _7DB94. doc, Last accessed 24 March 2005.
43. AM Walmsley ML Alvarez Y Jin DD Kirk SM Lee J Pinkhasov MM Rigano CJ Arntzen HS Mason 2003a Expression of the B subunit of Escherichia coli heat-labile enterotoxin as a fusion protein in transgenic tomato Plant Cell Rep 21 1020 1026
44. Walmsley AM, Rowland L, Kirk DD, Miller TJ and Mason HS (2003b) Efficacy of an edible, plantderived immunocontraceptive vaccine in mice and voles. In NFID Sixth annual conference on vaccine research, Arlington, VA, May 5-7.
45. J Yu WH Langridge 2001 A plant-based multicomponent vaccine protects mice from enteric diseases Nat Biotechnol 19 548 552
46. V Yusibov DC Hooper SV Spitsin N Fleysh RB Kean T Mikheeva D Deka A Karasev S Cox J Randall H Koprowski 2002 Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine Vaccine 20 3155 3164